PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

University of Cambridge, Cambridge, England, United Kingdom
Nature Genetics (Impact Factor: 29.65). 03/2007; 39(2):165-7. DOI: 10.1038/ng1959
Source: PubMed

ABSTRACT PALB2 interacts with BRCA2, and biallelic mutations in PALB2 (also known as FANCN), similar to biallelic BRCA2 mutations, cause Fanconi anemia. We identified monoallelic truncating PALB2 mutations in 10/923 individuals with familial breast cancer compared with 0/1,084 controls (P = 0.0004) and show that such mutations confer a 2.3-fold higher risk of breast cancer (95% confidence interval (c.i.) = 1.4-3.9, P = 0.0025). The results show that PALB2 is a breast cancer susceptibility gene and further demonstrate the close relationship of the Fanconi anemia-DNA repair pathway and breast cancer predisposition.

Download full-text


Available from: Sheila Seal, Jul 02, 2015
1 Follower